Immunotherapy treatment for leukemia in Germany focuses on strengthening immune response through advanced dendritic cell therapy, clinical trials, and expert care for international patients.
Details →
Learn about innovative leukaemia treatment in Germany, including dendritic cell immunotherapy led by Prof. Gansauge in Germany. Discover personalized care supported by TIG for international patients.
Details →
Acute Lymphoblastic Leukemia (ALL) is a type of blood and bone marrow cancer that affects the production of white blood cells. Early symptoms include fatigue, frequent infections, easy bruising, bleeding, bone pain, and fever.
Details →
Dendritic cell immunotherapy mobilizes dendritic cells, the immune system’s sentinels, to present leukemia-specific antigens to T-cells, sparking a precise attack on cancer cells.
Details →
Our benefits:
.webp)
 (1).webp)
.webp)
 (1).webp)
.jpg)
